CSIMarket Company Name, Ticker, Competitors, else..


Dexcom Inc   (NASDAQ: DXCM)
Other Ticker:  
 

Dexcom Inc

DXCM's Fundamental analysis



Looking into Dexcom Inc growth rates, revenue grew by 7.63 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 594

Medical Equipment & Supplies industry recorded deterioration of revenues by -2.28 %

Dexcom Inc 's net profit decreased by -40.81 % in IV. Quarter 2024 year on year, to $152 millions.

• More on DXCM's Growth


Dexcom Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Dexcom Inc PEG ratio is at 4.32 Company is currently trading with Price to Cash flow multiple of 720.71 in trailing twelve-month period.
Company
49.15
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.11.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.


• More on DXCM's Valuation
 
 Total Debt (Millions $) 2,441
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 420,021
 Net Income/Employee (TTM) $ 60,021
 Receivable Turnover (TTM) 4.1
 Tangible Book Value (Per Share $) 4.87

Dexcom Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Dexcom Inc PEG ratio is at 4.32 Company is currently trading with Price to Cash flow multiple of 720.71 in trailing twelve-month period.
Company
49.15
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.11.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.

Dexcom Inc Price to Book Ratio is at 13.64 higher than Industry Avg. of -156.92, and higher than S&P 500 Avg. of 0.01

• More on DXCM's Valuation

•  Market Capitalization (Millions $) 28,684
•  Shares Outstanding (Millions) 406
•  Employees 9,600
•  Revenues (TTM) (Millions $) 4,032
•  Net Income (TTM) (Millions $) 576
•  Cash Flow (TTM) (Millions $) 40
•  Capital Exp. (TTM) (Millions $) -359
•  Total Debt (Millions $) 2,441
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 420,021
•  Net Income/Employee(TTM) $ 60,021
•  Receivable Turnover Ratio (TTM) 4.1
•  Tangible Book Value (Per Share $) 4.87

•  Market Capitalization (Millions $) 28,684
•  Shares Outstanding (Millions) 406
•  Employees 9,600
•  Revenues (TTM) (Millions $) 4,032
•  Net Income (TTM) (Millions $) 576
•  Cash Flow (TTM) (Millions $) 40
•  Capital Exp. (TTM) (Millions $) -359


    DXCM's Profitability Comparisons
Dexcom Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 16.96 % from 15.29 % in III. Quarter.

Dexcom Inc net profit margin of 13.62 % is currently ranking no. 18 in Medical Equipment & Supplies industry, ranking no. 70 in Healthcare sector and number 870 in S&P 500.


Profitability by Segment
Total 13.54 %



  Ratio
•   Capital Ratio (MRQ) 1.48
•  Total Debt to Equity (MRQ) 1.16
•  Tangible Leverage Ratio (MRQ) 2.17
•  Asset Turnover Ratio (TTM) 0.62
•  Inventory Turnover Ratio (TTM) 2.79



Dexcom Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 16.96 % from 15.29 % in III. Quarter.

Dexcom Inc net profit margin of 13.62 % is currently ranking no. 18 in Medical Equipment & Supplies industry, ranking no. 70 in Healthcare sector and number 870 in S&P 500.

• More on DXCM's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com